Intervention

QBW251

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT04268823 · 2020-09-10

Dose-range Finding Efficacy and Safety Study for QBW251 in COPD PatientsNCT04072887 · 2019-09-12

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251NCT02449018 · 2015-04-30

Common conditions

Chronic Obstructive Pulmonary Disease1 Chronic Obstructive Pulmonary Disease, COPD1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

Novartis Pharmaceuticals3

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.